Clinical trial
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other…
NCT00024258 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00024258 |
|---|---|
| Title | Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors |
| Official title | Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Kidney Cancer, Liver Cancer, Neuroblastoma, Ovarian Cancer, Retinoblastoma, Sarcoma |
| Intervention type | Drug |
| Interventions | arsenic trioxide |
| Enrollment | 22 |
| Start date | Mar 1, 2001 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: